Antimicrobial Prophylaxis Practice Patterns in Breast Augmentation: A National Survey of Current Practice.

Annals of plastic surgery 2017 Vol.78(6) p. 629-632

Chopra K, Gowda AU, McNichols CHL, Brown EN, Slezak S, Rasko Y

관련 도메인

Abstract

[BACKGROUND] Breast augmentation is one of the most commonly performed aesthetic surgery procedures worldwide. Bacterial contamination is of paramount concern due to its role in biofilm formation and capsular contracture. Plastic surgeons have adopted a variety of perioperative interventions in efforts to reduce implant contamination, however definitive evidence supporting these practices is lacking.

[OBJECTIVE] The goal of this study was to assess current practice patterns aimed at reducing implant-related infections in breast augmentation and comparing them to current evidence-based medicine recommendations.

[METHODS] A 20-question survey assessing practices aimed at preventing breast implant associated infections was generated and distributed via SurveyMonkey to members of the American Society of Plastic Surgery whose electronic mail addresses were listed on the American Society of Plastic Surgery member website in April 2015.

[RESULTS] A total of 253 responses were received from the survey. Of the respondents, 81% were in private practice. Respondents averaged 21 ± 9 years in practice, and 69 ± 111 breast augmentations performed per year. A majority of surgeons used Chlorhexidine to prepare the surgical site (45%) and triple antibiotic solution both as a soak for the implant before placement (40%) as well as for implant pocket irrigation (47%). A no-touch technique using the Keller Funnel was adopted by 42% of surgeons. Regarding antibiotic use in the postoperative period, first-generation cephalosporins were used by the majority of respondents (79%), and the most common duration was for 4 to 6 days (45%).

[CONCLUSIONS] Although there is heterogeneity in specific aspects of antimicrobial prophylaxis during breast augmentation, there is a clear trend toward practice modification geared towards preventing bacterial contamination in breast augmentation. Surgeons may benefit from high-level studies designed to create standardized evidence-based practice guidelines.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 7
시술 breast augmentation 유방성형술 dict 5
합병증 capsular contracture 피막구축 dict 1
합병증 breast implant associated 보형물연관 역형성대세포림프종 dict 1
약물 ± 111 breast scispacy 1
약물 Chlorhexidine C0008196
chlorhexidine
scispacy 1
약물 cephalosporins C3536856
Cephalosporins
scispacy 1
약물 [BACKGROUND] Breast scispacy 1
약물 biofilm scispacy 1
약물 [OBJECTIVE] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 implant-related infections scispacy 1
질환 breast implant C0178391
breast implant procedure
scispacy 1
질환 infections C0851162
Infections of musculoskeletal system
scispacy 1
기타 capsular scispacy 1

MeSH Terms

Anti-Infective Agents; Antibiotic Prophylaxis; Breast Implants; Female; Humans; Infection Control; Mammaplasty; Practice Patterns, Physicians'; Prosthesis-Related Infections; Surgical Wound Infection; Surveys and Questionnaires; Treatment Outcome; United States

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문